Previously, the use of Veklury, a Gilead Sciences Inc. drug, was limited to those requiring hospitalization.
A new, wearable device may help alert you if you are exposed to COVID-19. Researchers at the Yale School of Public Health developed an easy-to-clip-on device that can help detect low levels of SARS-COV-2 and subsequently whether a person has been exposed.
The agency has expanded the approved indication for Veklury to include its use in adults and pediatric patients 12 years and older – and weighing at least 88 pounds – with positive results of direct SARS-CoV-2 viral testing and who are not hospitalized, have mild-to-moderate COVID-19 and are at high risk for progression to severe disease.
"The main outcome measured in the trial was whether a patient was hospitalized for any COVID-19 related reason or died from any reason within 28 days of treatment. Overall, two of 279 patients who received Veklury required COVID-19 related hospitalization compared to 15 of 283 patients who received a placebo . There were no deaths in either group," the FDA said.
"Remdesivir has now helped to treat more than 10 million people around the world with COVID-19 and continues to play a key role in helping to reduce the burden of the pandemic. Based on the most recent data, we now understand that remdesivir is also effective in the early stages of COVID-19 infection, in addition to helping patients who are hospitalized with the disease," Daniel O’Day, the CEO of Gilead Sciences, said in a separate statement.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA authorizes antiviral drug remdesivir for non-hospitalized COVID patientsThe FDA today authorized the antiviral drug remdesivir as a treatment for some non-hospitalized adults and pediatric patients with mild to moderate COVID symptoms.
Les mer »
Utah eliminates race and sex as factors in monoclonal antibody COVID treatments after ‘legal concerns’After complaints by right-wing media personalities, Utah is eliminating race and sex as factors in allocating its limited supply of monoclonal antibodies and antiviral treatments for COVID-19.
Les mer »
COVID-19 live updates: Hospitalizations at record highTwo years ago today, the U.S. reported its first known case of the new virus circulating in China. To date, COVID-19 has killed over 860,000 Americans.
Les mer »
COVID-19 live updates: Breakthrough cases grew fourfold during omicronCOVID-19 LATEST: Beginning Saturday, the Department of Homeland Security is requiring non-U.S. citizens entering the U.S. via land or ferry to be fully vaccinated.
Les mer »
'I'm 29 years old and I feel like I'm 70': Long COVID patients continue to struggle for months, yearsCOVID-19 long haul patients are struggling with doctors and employers as they battle lingering symptoms that make them feel 'crazy.'
Les mer »
Is omicron really less severe? ICUs more slammed than ever, doctors sayICUs nationwide were already overwhelmed with chronically ill patients — many sick with Covid-19 and related illnesses — when omicron hit.
Les mer »